IRIS
GALLO CANTAFIO, MARIA EUGENIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 998
AS - Asia 735
EU - Europa 402
SA - Sud America 137
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 3
Totale 2.298
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 959
SG - Singapore 372
IT - Italia 220
CN - Cina 144
BR - Brasile 100
VN - Vietnam 83
IN - India 52
DE - Germania 48
GB - Regno Unito 36
HK - Hong Kong 32
CA - Canada 24
FI - Finlandia 21
SE - Svezia 21
AR - Argentina 12
NL - Olanda 12
BD - Bangladesh 11
MX - Messico 8
EU - Europa 6
PL - Polonia 6
RU - Federazione Russa 6
CL - Cile 5
CZ - Repubblica Ceca 5
EC - Ecuador 5
VE - Venezuela 5
YE - Yemen 5
AT - Austria 4
EG - Egitto 4
ID - Indonesia 4
IQ - Iraq 4
MA - Marocco 4
RO - Romania 4
AU - Australia 3
CH - Svizzera 3
ES - Italia 3
FR - Francia 3
HR - Croazia 3
JO - Giordania 3
KE - Kenya 3
PE - Perù 3
PK - Pakistan 3
PY - Paraguay 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
CO - Colombia 2
DO - Repubblica Dominicana 2
IR - Iran 2
MY - Malesia 2
UA - Ucraina 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AZ - Azerbaigian 1
BO - Bolivia 1
CG - Congo 1
CR - Costa Rica 1
CV - Capo Verde 1
CY - Cipro 1
GM - Gambi 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LT - Lituania 1
MN - Mongolia 1
NP - Nepal 1
PR - Porto Rico 1
PT - Portogallo 1
RS - Serbia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TR - Turchia 1
TW - Taiwan 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 2.298
Salva come PNG Salva come JPEG
Città #
San Jose 209
Singapore 161
Ashburn 102
Chandler 85
Dallas 56
Santa Clara 56
Bengaluru 42
Hefei 42
Munich 40
Catanzaro 38
Ho Chi Minh City 34
Hong Kong 32
Chicago 28
Milan 28
Beijing 24
Lawrence 24
London 24
Princeton 24
Hanoi 19
Turku 16
Los Angeles 14
São Paulo 13
New York 12
Rome 11
Wilmington 11
Des Moines 10
Ottawa 10
Bari 9
Reggio Calabria 9
Boardman 7
Brooklyn 7
Montreal 7
Naples 7
Rio de Janeiro 6
San Nicola Manfredi 6
Warsaw 6
Helsinki 5
Manchester 5
Olomouc 5
San Francisco 5
Sanaa 5
The Dalles 5
Biên Hòa 4
Cosenza 4
Da Nang 4
Haiphong 4
Phoenix 4
Siano 4
Ahmedabad 3
Amman 3
Berlin 3
Boston 3
Can Tho 3
Castrovillari 3
Charlotte 3
Chennai 3
Giugliano in Campania 3
Lima 3
Nairobi 3
Norwalk 3
Praia Grande 3
Redwood City 3
San Antonio 3
San Prisco 3
Stockholm 3
Tongi 3
Vienna 3
6th of October City 2
Amsterdam 2
Atlanta 2
Bacoli 2
Bady Bassitt 2
Belo Horizonte 2
Buffalo 2
Casablanca 2
Ceglie Del Campo 2
Columbus 2
Cortale 2
Council Bluffs 2
Dhaka 2
Florianópolis 2
Grottaglie 2
Guayaquil 2
Horia 2
Irsina 2
Itabira 2
Jakarta 2
Jeddah 2
Kansas City 2
Kota Samarahan 2
Mexico City 2
Osijek 2
Porto Alegre 2
Quận Bình Thạnh 2
Redmond 2
Roccella Ionica 2
San Polo di Torrile 2
Santo Stefano di Rogliano 2
Settingiano 2
Shanghai 2
Totale 1.406
Salva come PNG Salva come JPEG
Nome #
miR-22 suppresses DNA ligase III addiction in multiple myeloma 103
A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells 89
MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells 83
IL-6 Receptor Blockade by Tocilizumab Has Anti-absence and Anti-epileptogenic Effects in the WAG/Rij Rat Model of Absence Epilepsy 78
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 75
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. (CO-FIRST AUTHOR) 75
miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma 73
MiR-34a Replacement As a Novel Therapeutic Approach for Multiple Myeloma: Preclinical In Vitro and In Vivo Evidence 70
Effects of Histone Deacetylase Inhibitors on the Development of Epilepsy and Psychiatric Comorbidity in WAG/Rij Rats 70
Anti-tumor Activity and Epigenetic Impact of the Polyphenol Oleacein in Multiple Myeloma 69
Oleil hydroxytyrosol (Htol) exerts anti-myeloma activity by antagonizing key survival pathways in malignant plasma cells (CO-FIRST AUTHOR) 65
A Comparison of Different Sample Processing Protocols for MALDI Imaging Mass Spectrometry Analysis of Formalin-Fixed Multiple Myeloma Cells 64
Influence of the fabrication accuracy of hot-embossed PCL scaffolds on cell growths 63
From single level analysis to multi-omics integrative approaches: A powerful strategy towards the precision oncology 61
In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells (CO-FIRST AUTHOR) 58
A Comparison of Different Sample Processing Protocols for MALDI Imaging Mass Spectrometry Analysis of Formalin-Fixed Multiple Myeloma Cells 56
Pharmacokinetics and Pharmacodynamics of a 13-mer LNA-inhibitor-miR-221 in Mice and Non-human Primates 54
Therapeutic activation of G protein-coupled estrogen receptor 1 in Waldenström Macroglobulinemia 53
In Vitro and in Vivo Anti-tumor Activity of miR-221/222 Inhibitors in Multiple Myeloma 53
In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma 53
Mitochondrial Determinants of Anti-Cancer Drug-Induced Cardiotoxicity 52
Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activity (CO-FIRST AUTHOR) 51
Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence 48
Natural Agents as Novel Potential Source of Proteasome Inhibitors with Anti-Tumor Activity: Focus on Multiple Myeloma 47
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity 47
Palmitate-Induced Cardiac Lipotoxicity Is Relieved by the Redox-Active Motif of SELENOT through Improving Mitochondrial Function and Regulating Metabolic State 47
From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology 46
Hit Identification and Functional Validation of Novel Dual Inhibitors of HDAC8 and Tubulin Identified by Combining Docking and Molecular Dynamics Simulations 45
CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents 43
null 43
Non-Coding RNA-Dependent Regulation of Mitochondrial Dynamics in Cancer Pathophysiology 42
Transferrin-conjugated SNALPs encapsulating 2'-O-methylated miR-34a for the treatment of multiple myeloma 42
In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells 40
BET inhibitors (BETi) influence oxidative phosphorylation metabolism by affecting mitochondrial dynamics leading to alterations in apoptotic pathways in triple-negative breast cancer (TNBC) cells 38
Non-Coding RNA-Dependent Regulation of Mitochondrial Dynamics in Cancer Pathophysiology 38
Lipid metabolic vulnerabilities of multiple myeloma (CO-FIRST AUTHOR) 38
Fingolimod Exerts only Temporary Antiepileptogenic Effects but Longer-Lasting Positive Effects on Behavior in the WAG/Rij Rat Absence Epilepsy Model 37
Lipid metabolic vulnerabilities of multiple myeloma (CO-FIRST AUTHOR) 36
Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma 36
null 31
GPER1 Activation Exerts Anti-Tumor Activity in Multiple Myeloma 30
Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo 30
New Insights for Polyphenolic Compounds as Naturally Inspired Proteasome Inhibitors (CO-FIRST AUTHOR) 29
Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myeloma (FIRST AUTHOR) 20
Cytogenetic and molecular characterization of an atypical ETP-ALL case with BCL2 dependency: therapeutic implications for Venetoclax use 19
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92 12
null 11
Targeting Mitochondrial Vulnerabilities in Chronic Myeloid Leukemia: From Pathobiology to Novel Therapeutic Opportunities 7
Targeting the MARCH5-MFN2 axis to enhance mitochondrial fusion and sensitize multiple myeloma cells to venetoclax 2
Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myeloma 1
null 1
Totale 2.374
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.720
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.720
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202299 0 0 0 15 7 5 9 14 13 20 15 1
2022/2023259 48 16 18 10 28 24 3 20 42 15 19 16
2023/2024143 36 26 6 11 7 33 5 0 0 1 7 11
2024/2025531 55 17 21 25 29 77 26 15 45 39 76 106
2025/20261.232 93 108 129 155 145 75 164 106 100 112 38 7
Totale 2.374